Mumbai:  Mumbai – based Ujin Pharma Limited receives final SEBI approval for IPO

The Company had filed its IPO papers with SEBI on 22 June, 2026.

The IPO consists of a fresh issue of up to 11,869,100 equity shares and an offer-for-sale for up to 7,282,300 equity shares by promoters – Jinesh Rasiklal Sheth and Umang Ketan Mehta.

The proceeds from its fresh issuance worth Rs 61.7 crore will be utilised for investment in Altra Agro-Chem Private Limited – the company’s associate company, by way of subscription to equity shares for making it their subsidiary, Rs 21.6 crore in investment in Altra Pharma-Chem Private Limited, its associate company, by way of subscription to equity shares for making it their subsidiary, Rs 25 crore for repayment or pre-payment, in part or full, of certain borrowings availed by the company from financial institutions, and general corporate purposes.

Incorporated in 2005, the company is engaged in the distribution and supply of a diversified portfolio of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials and nutraceuticals. With over two decades of operational experience in the chemical industry, the company has developed sourcing relationships with domestic and international suppliers, enabling it to procure a broad range of chemical products and supply them to traders, distributors and customers operating across multiple end-use industries.

The company’s products are supplied to customers operating in pharmaceutical, agrochemical, specialty chemical, petrochemical, industrial and automotive sectors, as well as paints and coatings, printing inks and packaging applications.